150 related articles for article (PubMed ID: 10896391)
1. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
[TBL] [Abstract][Full Text] [Related]
2. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
[TBL] [Abstract][Full Text] [Related]
3. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
4. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
6. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).
Olivry T; Borrillo AK; Xu L; Dunston SM; Slovis NM; Affolter VK; Demanuelle TC; Chan LS
Vet Immunol Immunopathol; 2000 Jan; 73(1):45-52. PubMed ID: 10678397
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285.
Palmer RA; Ogg G; Allen J; Banerjee A; Ryatt KS; Ratnavel R; Wojnarowska F
Br J Dermatol; 2001 Nov; 145(5):816-20. PubMed ID: 11736908
[TBL] [Abstract][Full Text] [Related]
8. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
9. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
10. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
[TBL] [Abstract][Full Text] [Related]
11. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
12. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
[TBL] [Abstract][Full Text] [Related]
13. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
[No Abstract] [Full Text] [Related]
14. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
[TBL] [Abstract][Full Text] [Related]
15. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
[TBL] [Abstract][Full Text] [Related]
16. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
Hsu S; Ghohestani RF; Uitto J
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
[TBL] [Abstract][Full Text] [Related]
19. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antibody response in oesophageal cicatricial pemphigoid.
Egan CA; Hanif N; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
Br J Dermatol; 1999 May; 140(5):859-64. PubMed ID: 10354023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
